News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
Melinta Therapeutics Announces Presentations of New Data on Infectious Disease Portfolio at IDWeek 2023
October 11, 2023Press Release PARSIPPANY, N.J.–Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses,...
Melinta Therapeutics Announces Expanded Reimbursement and Access for REZZAYO™ (rezafungin for injection)
October 2, 2023Press ReleaseREZZAYO receives product-specific J-Code and is granted NTAP PARSIPPANY, N.J., October 2, 2023 – Melinta Therapeutics (Melinta), a commercial-stage company providing...
MELINTA THERAPEUTICS ANNOUNCES COMMERCIAL AVAILABILITY OF REZZAYO™ (rezafungin for injection)
July 31, 2023Press ReleaseNew Treatment for Candidemia and Invasive Candidiasis Now Available in the U.S PARSIPPANY, NJ, July 31, 2023 –Melinta Therapeutics, LLC today announced the availability...